Physicians and patients should be aware of the likelihood of Descemet’s membrane endothelial keratoplasty graft failure and the need for repeat transplantation in the presence of previous glaucoma surgery, according to a study.“We initially conducted a…
Author: Healio ophthalmology
New funding allows Azura to advance study of MGD treatment
Azura Ophthalmics has raised $20 million in financing for registration studies of its lead clinical candidate for treatment of meibomian gland dysfunction, according to a press release.The company received the round of funding after receipt of “encoura…
ESCRS coverage includes lessons from ‘greatest team of cataract surgeons’
Healio/OSN recently covered the virtual European Society of Cataract and Refractive Surgeons meeting, with popular items including lessons from cataract surgeons, research on capsular tension rings and video perspectives.Five lessons can be learned fro…
VIDEO: Post hoc analysis shows high patient satisfaction with iStent inject
In this OSN Video Perspective from the virtual ESCRS meeting, Blake Williamson, MD, discusses patient satisfaction and other variables from a post hoc analysis of patients implanted with the iStent inject from Glaukos.
Q&A with Laura Periman, MD: Opening an ophthalmic institute amid COVID-19
Laura M. Periman, MD, is a fellowship-trained cornea and refractive surgeon and ocular surface disease expert who is in love with the fast pace of discovery that the ocular surface demands.With her profound interest in dry eye disease acting as a catal…
FDA approves remdesivir, first treatment for COVID-19
The FDA has approved Gilead Science’s antiviral IV drug remdesivir — also known as Veklury — for adults and children aged older than 12 years when treatment of COVID-19 requires hospitalization.The drug is the first approved therapy for COVID-19.The ap…
Artis Symbiose IOL performs at all distances
The Artis Symbiose IOL provides sharp, continuous vision at all distances with fast adaptation, according to one specialist.“The through-focus continuous phase ensures image sharpness without the gap that we normally see in the defocus curve at interme…
Teprotumumab confers long-term benefits in thyroid eye disease
Adults with active thyroid eye disease assigned the human monoclonal antibody teprotumumab experienced improvements in disease outcomes that persisted nearly 1 year after receiving the last trial dose, new study data show.“These findings indicate that …
C3 inhibitor may prevent progression from nascent to manifest geographic atrophy
A post hoc analysis of the phase 2 FILLY study demonstrated that patients who received multiple intravitreal injections of pegcetacoplan had a lower rate of progression from nascent geographic atrophy to GA as compared with sham.“We were able to demons…
Deadline approaches for health care provider relief funding
HHS announced that health care providers on the frontlines of the COVID-19 pandemic coronavirus pandemic have until Nov. 6 to apply for a portion of $20 billion in new funding.According to a press release, the funding is earmarked for health care provi…
Tarsus closes initial public offering
The initial public offering for Tarsus Pharmaceuticals has closed, bringing in about $101.2 million, according to a press release.The IPO consisted of 6,325,000 shares of common stock at a price of $16 per share. This includes 825,000 shares sold upon …
Significant improvement observed in X-linked retinitis pigmentosa treated with AAV-RPGR
Nine-month data from a phase 1/2 clinical trial of AAV-RPGR gene therapy for X-linked retinitis pigmentosa showed clinically meaningful improvement in retinal sensitivity and vision-guided mobility.“The most significant finding is that treatment can re…
FDA classifies KDB Glide as Class 1 device
The FDA has registered New World Medical’s KDB Glide as a Class 1 device, which will soon be available in the U.S., according to a company press release.The KDB Glide adds a rounded heel, tapered sides and a smaller footplate to the company’s Kahook Du…
Q&A: How would Supreme Court nominee rule on health care issues?
The Senate Judiciary Committee is expected to vote on Amy Coney Barrett’s nomination to the Supreme Court tomorrow, Oct. 22.Health experts told Healio Primary Care that they are concerned with her possible ascension from the 7th U.S. Circuit Court of A…
Many physicians experience — but do not report — sexual harassment
Sexual harassment is common among physicians, but many do not report incidents even though they negatively affect their personal and professional lives, according to research presented during the virtual Women in Medicine Summit.When physicians did rep…
Reducing drop burden after cataract surgery can improve patient compliance, reduce costs
Dropless or reduced drop cataract surgery can improve patient compliance, reduce costs, reduce ocular surface damage, and increase patient satisfaction and convenience, according to a speaker.“The advantages of dropless over traditional drops can be su…
Gender differences in physician burnout are mixed, skew toward women
Studies have shown that among physicians in the fields surgery, obstetrics and anesthesiology, or SOA, women are more likely to experience emotional exhaustion, but men have higher rates of depersonalization.However, women are much more likely than men…
Sustained-release glaucoma medications needed to reduce treatment burden
Between poor patient adherence and the inherent IOP peaks and troughs associated with eye drop-managed glaucoma, sustained-release medications are greatly needed, a presenter at the virtual OSN New York meeting said.About half of all patients taking ey…
Gene therapy may represent future of AMD treatment
Gene therapy represents a new potential avenue for the treatment of retinal diseases, including age-related macular degeneration, according to a presenter at the virtual OSN New York Retina meeting.“Gene therapy is an exciting new treatment approach in…
Weakness, blurred vision in a young woman with headaches
A 28-year-old woman presented to the department of ophthalmology at Lahey Hospital and Medical Center with 2 months of headaches and progressive visual changes in both eyes.Two months before presentation, she was evaluated by an outside retina speciali…